A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma-Reference-Cited by-同舟云学术

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma

Published:2024-05-21 Issue:6 Volume:30 Page:1667-1679
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kinget Lisa^ORCID,Naulaerts Stefan,Govaerts Jannes,Vanmeerbeek Isaure,Sprooten Jenny,Laureano Raquel S.,Dubroja Nikolina,Shankar Gautam,Bosisio Francesca M.^ORCID,Roussel Eduard,Verbiest Annelies,Finotello Francesca^ORCID,Ausserhofer Markus,Lambrechts Diether^ORCID,Boeckx Bram,Wozniak Agnieszka,Boon Louis,Kerkhofs Johan,Zucman-Rossi Jessica^ORCID,Albersen Maarten,Baldewijns Marcella,Beuselinck Benoit^ORCID,Garg Abhishek D.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41591-024-02978-9.pdf

Reference92 articles.

1. Motzer, R. J. et al. Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade. Cancer Cell 38, 803–817.e4 (2020).

2. Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers 3, 17009 (2017).

3. Borràs, D. M. et al. Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer. Cell Discov. 9, 114 (2023).

4. Sprooten, J. et al. Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer. J. Immunother. Cancer 9, e003609 (2021).

5. Naulaerts, S. et al. Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer. Sci. Transl. Med. 15, eadd1016 (2023).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation DC vaccines with an immunogenic trajectory against cancer: therapeutic opportunities vs. resistance mechanisms;Genes & Immunity;2024-08-27

2. Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab;Acta Oncologica;2024-08-11

3. Temporo‐frontoparietal hypoconnectivity as a biomarker for isolated language impairment in mild cognitive impairment: A cross‐cohort comparison;Alzheimer's & Dementia;2024-08-08

4. Can Sarcomatoid Features Guide the Use of Adjuvant Atezolizumab Following Nephrectomy? Probably Not;European Urology Oncology;2024-08